Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-000180
Filing Date
2022-01-03
Accepted
2022-01-03 19:53:03
Documents
1
Period of Report
2021-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3088
  Complete submission text file 0000899243-22-000180.txt   4488
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1305 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Valantine Hannah (Reporting) CIK: 0001855608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 22503596